Initial Investigation of Vericiguat Efficacy in the Treatment of Recurrently Hospitalised Heart Failure Patients
Vericiguat can be added for the treatment of patients with a reduced ejection fraction and episodes of decompensation, showing promising results in decreasing additional hospitalisations and improving the clinical outcomes of patients.
Authors
- Kārlis Trušinskis (ORCID: https://orcid.org/0000-0001-5529-8113)
- Aleksandrs Vasiljevs
Institutions
- Latvia University of Life Sciences and Technologies (LV)
- Pauls Stradiņš Clinical University Hospital (LV)
- Riga Stradiņš University (LV)
- University of Latvia (LV)
Publication Details
- Journal
- Cureus
- Published
- 2025-08-28
- DOI
- https://doi.org/10.7759/cureus.91192
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00